Drugmakers to join forces to make millions of Ebola vaccine doses
Wednesday, October 22, 2014
Leading drugmakers plan to work together to accelerate development of an Ebola vaccine and produce millions of doses of the most effective experimental product for use next year.
Johnson & Johnson said on Wednesday that it aims to produce at least 1 million doses of its two-step vaccine next year and has already discussed collaboration with Britain’s GlaxoSmithKline, which is working on a rival vaccine.
The U.S. group’s head of research Paul Stoffels said the two companies would support each other’s work and could combine their vaccines if that made sense, while other companies without an Ebola treatment are ready to provide production capacity.
There is currently no proven vaccine against the deadly disease but several companies are racing to develop products.
- Health Care